Expertise in
6
conditions

Roberto Ferrara

Milan, IT 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
6
conditions
Milan, IT 

Overview

Roberto Ferrara practices practicing medicine in Milan, Italy.

Mr. Ferrara is highly rated in 6 conditions, according to our data. His clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, EGFR Positive Lung Cancer, Small Cell Lung Cancer (SCLC), and Tissue Biopsy.

He is actively involved in clinical research, co-authoring 148 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Milan, Italy
Other Locations
Rome, 00184, Italy
Latina, Italy
Verona, 37134, Italy

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 1/2, Open-Label, Multi-Center, First-in-Human Study of the Safety, Tolerability, Pharmacokinetics, and Anti-Tumor Activity of TPX-0005 in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements (TRIDENT-1)
A Phase 1/2, Open-Label, Multi-Center, First-in-Human Study of the Safety, Tolerability, Pharmacokinetics, and Anti-Tumor Activity of TPX-0005 in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements (TRIDENT-1)
Enrollment Status: Recruiting
Publish Date: May 27, 2026
Intervention Type: Drug
Study Drug: Repotrectinib
Study Phase: Phase 1/Phase 2
The Effects of Dark Chocolate Implementation in the Reduction of Oxidative Stress and Improvement of Vascular Function and Physical Performance in Elite Athletes
The Effects of Dark Chocolate Implementation in the Reduction of Oxidative Stress and Improvement of Vascular Function and Physical Performance in Elite Athletes
Enrollment Status: Completed
Publish Date: April 17, 2019
Intervention Type: Dietary supplement
Study Phase: Not Applicable
View 1 Less Clinical Trial

148 Total Publications

Molecular bycatch in early-stage NSCLC: Keep, discard, or redefine?
Molecular bycatch in early-stage NSCLC: Keep, discard, or redefine?
Journal: European journal of cancer (Oxford, England : 1990)
Published: March 16, 2026

Frequently Asked Questions about Roberto Ferrara

Is Roberto Ferrara a top-rated expert for Non-Small Cell Lung Cancer (NSCLC)?

MediFind is an objective health platform that identifies experts based on real-world data. Roberto Ferrara is classified as an Elite expert for Non-Small Cell Lung Cancer (NSCLC), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Roberto Ferrara participate in research or clinical trials?

Yes. Roberto Ferrara has published 148 articles and abstracts on conditions like Non-Small Cell Lung Cancer (NSCLC). You can view a list of Roberto Ferrara's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Ferrara's expertise for a condition
ConditionClose
    View All 19 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile